VITC!
VersaTech, Inc. Takes Steps to Aggressively Expand Business
Activities
VersaTech, Inc. Takes Steps to Aggressively Expand Business Activities HAWLEY, Pa., Aug. 1 /PRNewswire/ -- VersaTech, Inc. (OTC Bulletin Board: VITC) is aggressively pursuing strategies to increase capitalization in order to expand business activities, the company announced today. "We are working to complete financing that will enable us to dramatically broaden the distribution of Unitropin and further the development of LongerLiving," said Steve Krakonchuk, Vice President of VersaTech, referring to the company's growth hormone-stimulating health supplement and multimedia Internet site. The company reports that the number of affiliates signed up through the Unitropin Commission Junction affiliate program is approaching 1,000. In addition, the product is now available directly for sale from the Unitropin website unitropin.com. "We expect the increased exposure we are receiving through our affiliate program and the easy accessibility of Unitropin to people now that it is on the web will lead to a surge in sales," said Michael Daily, President of VersaTech. However, the company is not stopping with just online distribution. "We are actively pursuing both wholesale and retail distribution in North America, and we are building the relationships necessary to distribute Unitropin internationally where we expect it to be extremely well-received, particularly in countries that traditionally value herbal medicine," continued Daily. Krakonchuk described the planned development of the LongerLiving Internet site as creating a high-tech health multimedia platform where consumers will have access to high quality, accurate, and timely health information in an enjoyable and entertaining format. In addition to offering information directly to consumers, the company anticipates a market helping medical institutions and associations convert their current static content into multimedia format. More information can be found at the company websites: -- versatechinc.com -- unitropin.com -- longerliving.com VersaTech, Inc. is publicly traded on the OTC Bulletin Board under the symbol "VITC". For further information contact Steve Krakonchuk (888) 222-9392 or (604) 214-9392 and visit the website at versatechinc.com. This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21 of the Securities Exchange Act of 1934 and are subject to the safe harbor provisions of those sections and the Private Securities Litigation Reform Act of 1995. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risk uncertainties including those described in the company's filings with the SEC, and that the actual results or developments may differ materially from those in the forward-looking statements as a result of various factors. The company has based these forward-looking statements on information currently available and disclaim any intention or obligation to update or revise any forward- looking statement. SOURCE VersaTech, Inc. -0- 08/01/2000 /CONTACT: Steve Krakonchuk of VersaTech, 888-222-9392 or 604-214-9392/ /Web site: unitropin.com / /Web site: longerliving.com / /Web site: versatechinc.com / -- PHTU011 -- 3518 08/01/2000 09:02 EDT prnewswire.com Copyright PR Newswire 1998. All rights reserved. |
